Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma

NCT04550624 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Carcinoma

Interventions

DRUG: Pembrolizumab Injection [Keytruda]
DRUG: Lenvatinib Mesylate

Sponsor

Shanghai Jiahui International Hospital

Collaborators

[object Object]